By contrast, compared with their non-TRM counterparts, tumor-infiltrating CD8 TRM cells more frequently express inhibitory molecules such as CD39 (the rate-limiting enzyme in the conversion of ATP to immunosuppressive adenosine) [15], programmed cell death-1 (PD-1), cytotoxic T lymphocyte antigen-4, lymphocyte activation gene-3, and T-cell immunoglobulin and mucin domain-3 while maintaining effector functions [7,16]. Here, ENTPD1 is linked to neoplasm.